228 related articles for article (PubMed ID: 34131795)
21. A comparison of the efficacy and tolerability of three corticosteroid treatment regimens in patients with alopecia areata.
Suchonwanit P; Kositkuljorn C; Mahasaksiri T; Leerunyakul K
J Dermatolog Treat; 2022 Mar; 33(2):756-761. PubMed ID: 32441159
[TBL] [Abstract][Full Text] [Related]
22. Transepidermal Delivery of Triamcinolone Acetonide or Platelet Rich Plasma Using Either Fractional Carbon Dioxide Laser or Micro-needling in Treatment of Alopecia Areata.
El Mulla KF; Elmorsy EH; Halwag DI; Hassan EM
Dermatol Pract Concept; 2022 Nov; 12(4):e2022196. PubMed ID: 36534509
[TBL] [Abstract][Full Text] [Related]
23. 308-nm excimer laser for the treatment of alopecia areata in children.
Al-Mutairi N
Pediatr Dermatol; 2009; 26(5):547-50. PubMed ID: 19840308
[TBL] [Abstract][Full Text] [Related]
24. Comparative Efficacy of Injection Triamcinolone Acetonide given Intralesionally and through Microneedling in
Arora A; Bhalla M; Thami GP
Int J Trichology; 2022; 14(5):156-161. PubMed ID: 36404886
[TBL] [Abstract][Full Text] [Related]
25. Childhood Alopecia Areata: An Overview of Treatment and Recent Patents.
Hon KL; Luk DCK; Leung AKC; Ng C; Loo SKF
Recent Pat Inflamm Allergy Drug Discov; 2020; 14(2):117-132. PubMed ID: 32723274
[TBL] [Abstract][Full Text] [Related]
26. Intramuscular Corticosteroid Therapy in the Treatment of Alopecia Areata: A Time-to-Event Analysis.
Chanprapaph K; Pomsoong C; Kositkuljorn C; Suchonwanit P
Drug Des Devel Ther; 2022; 16():107-116. PubMed ID: 35027820
[TBL] [Abstract][Full Text] [Related]
27. Stem cell-derived conditioned medium for alopecia: A systematic review and meta-analysis.
Chien WY; Huang HM; Kang YN; Chen KH; Chen C
J Plast Reconstr Aesthet Surg; 2024 Jan; 88():182-192. PubMed ID: 37983981
[TBL] [Abstract][Full Text] [Related]
28. A systematic review on the treatment of pediatric severe alopecia areata by topical immunotherapy or Anthralin (contact sensitization) or low-level light/laser therapy (LLLT): focus on efficacy, safety, treatment duration, recurrence, and follow-up based on clinical studies.
Behrangi E; Roohaninasab M; Sadeghzadeh-Bazargan A; Najar Nobari N; Ghassemi M; Seirafianpour F; Goodarzi A; Dodangeh M
J Cosmet Dermatol; 2022 Jul; 21(7):2727-2741. PubMed ID: 34606676
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and Influence Factors of 308-nm Excimer Lamp with Minoxidil in the Treatment of Alopecia Areata.
Li A; Meng X; Xing X; Tan H; Liu J; Li C
Lasers Surg Med; 2020 Oct; 52(8):761-767. PubMed ID: 31919885
[TBL] [Abstract][Full Text] [Related]
30. Is methotrexate an effective and safe treatment for maintaining hair regrowth in people with alopecia totalis? A Critically Appraised Topic.
Browne R; Stewart L; Williams HC
Br J Dermatol; 2018 Sep; 179(3):609-614. PubMed ID: 29777625
[TBL] [Abstract][Full Text] [Related]
31. Growth Factors and Microneedling in Alopecia Areata: A Narrative Review.
Almutlq MM; Bukhari AE
Skin Appendage Disord; 2024 Apr; 10(2):92-98. PubMed ID: 38572186
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: a randomized, double-blind placebo-controlled trial.
Tosti A; Iorizzo M; Botta GL; Milani M
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1243-7. PubMed ID: 17062039
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the efficacy and safety of 308-nm excimer laser with intralesional corticosteroids for the treatment of alopecia areata: A randomized controlled study.
Kianfar N; Dasdar S; Mahmoudi H; Abedini R; Fahim S; Hosseini SA; Daneshpazhooh M
Lasers Surg Med; 2022 Apr; 54(4):502-510. PubMed ID: 34859460
[TBL] [Abstract][Full Text] [Related]
34. Use of adapalene in alopecia areata: Efficacy and safety of mometasone furoate 0.1% cream versus combination of mometasone furoate 0.1% cream and adapalene 0.1% gel in alopecia areata.
Unal M
Dermatol Ther; 2018 Jan; 31(1):. PubMed ID: 29193637
[TBL] [Abstract][Full Text] [Related]
35. 308-nm excimer laser for the treatment of alopecia areata.
Al-Mutairi N
Dermatol Surg; 2007 Dec; 33(12):1483-7. PubMed ID: 18076615
[TBL] [Abstract][Full Text] [Related]
36. Carbon Dioxide Fractional Laser Treatment Induces Lgr5+ Stem Cell Activation and Hair Regrowth Through the Canonical Wnt/β-Catenin Pathway.
Sun R; Luo Y; Liu J; Shi L; Zhang Y
Aesthetic Plast Surg; 2024 May; 48(9):1831-1845. PubMed ID: 38155292
[TBL] [Abstract][Full Text] [Related]
37. Targeted photochemotherapy in alopecia areata.
Açıkgöz G; Yeşil H; Çalışkan E; Tunca M; Akar A
Photodermatol Photoimmunol Photomed; 2013 Dec; 29(6):318-22. PubMed ID: 24102724
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of fractional lasers in treating alopecia: a literature review.
Perper M; Aldahan AS; Fayne RA; Emerson CP; Nouri K
Lasers Med Sci; 2017 Nov; 32(8):1919-1925. PubMed ID: 28812164
[TBL] [Abstract][Full Text] [Related]
39. Hair Regrowth Outcomes of Contact Immunotherapy for Patients With Alopecia Areata: A Systematic Review and Meta-analysis.
Lee S; Kim BJ; Lee YB; Lee WS
JAMA Dermatol; 2018 Oct; 154(10):1145-1151. PubMed ID: 30073292
[TBL] [Abstract][Full Text] [Related]
40. A prospective comparative study of two regimens of diphenylcyclopropenone (DPCP) in the treatment of alopecia areata.
Al Bazzal A; Hatami P; Abedini R; Etesami I; Ayanian Z; Ghandi N
Int Immunopharmacol; 2021 Dec; 101(Pt B):108186. PubMed ID: 34710658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
